Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
116,964,738
-
Total 13F shares
-
55,358,578
-
Share change
-
-6,696,363
-
Total reported value
-
$40,439,575
-
Put/Call ratio
-
34%
-
Price per share
-
$0.7313
-
Number of holders
-
109
-
Value change
-
-$4,928,963
-
Number of buys
-
47
-
Number of sells
-
52
Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q2 2025
As of 30 Jun 2025 Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) had 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 55,358,578 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, Kohlberg Kravis Roberts & Co. L.P., GEODE CAPITAL MANAGEMENT, LLC, CM Management, LLC, STATE STREET CORP, C WorldWide Group Holding A/S, MILLENNIUM MANAGEMENT LLC, and CITIGROUP INC.
This table shows 109 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.